Establishing secure connection…Loading editor…Preparing document…

Dexter Corp Annual Report 10-K Exhibit 10F

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

The Dexter Corporation Senior Management Executive Incentive Plan

July 1997 20-159A

EXHIBIT B

1. Purpose.

The purpose of The Dexter Corporation Senior Management Executive Incentive Plan is to enhance the ability of the Company to attract, motivate, reward and retain executive officers and to align their interests with those of the Company's stockholders by providing additional cash compensation to designated executive officers of the Company based on the achievement of objective performance targets.

2. Definitions.

(a) "Award" shall mean an incentive award earned by a Participant under the Plan for a Performance Period.

(b) "Base Salary" for a Performance Period shall mean the Participant's base salary during such Performance Period.

(c) "Board" shall mean the Board of Directors of the Company.

(d) "Committee" shall mean the Compensation and Organization Committee of the Board.

(e) "Company" shall mean The Dexter Corporation, its successors and assigns.

(f) "Disability" shall mean permanent disability, as provided in the Company's long-term disability plan.

(g) "Division" shall mean a division of the Company as may be designated by the Committee.

(h) "Division Contribution" for any Performance Period shall mean net income for such period, before acquisition charges, interest expense, LIFO gain or loss, other nonoperating charges, taxes on income and minority interest income.

(i) "Earnings Per Share" for any Performance Period shall mean the consolidated net income of the Company for such period, divided by the weighted average number of shares of the Company's common stock.

(j) "Participant", for any Performance Period, shall mean an executive officer selected by the Committee to participate in the Plan for such Performance Period.

(k) "Performance Criteria" shall mean Earnings Per Share, Return on Equity, Revenues, Division Contribution, or any combination of the foregoing.

(l) "Performance Period" shall mean the fiscal year of the Company or any other period designated by the Committee with respect to which an Award is earned.

(m) "Performance Target" shall mean a financial target for a Performance Period expressed in one or more Performance Criteria.

(n) "Plan" shall mean this Senior Management Executive Incentive Plan, as from time to time amended and in effect.

(o) "Retirement" shall mean retirement at age 65 or early retirement with the prior written approval of the Company.

(p) "Return on Equity" for any Performance Period shall mean consolidated net income divided by average shareholder equity.

(q) "Revenues" for any Performance Period shall mean the consolidated net sales of the Company or the net sales of a Division, as applicable.

(r) "Subsidiary" shall mean a corporation defined in Section 424(f) of the Internal Revenue Code of 1986, as amended.

(s) "Target Award Percentage" for a Participant with respect to any Performance Period shall mean the percentage of the Participant's Base Salary that the Participant would earn as an Award.

3. Eligibility.

Participation in the Plan for a Performance Period shall be limited to executive officers selected by the Committee.

To be eligible to receive an Award for any Performance Period a Participant must be actively employed by the Company on each day of the Performance Period.

4. Administration.

The administration of the Plan shall be consistent with the purpose and the terms of the Plan. The Plan shall be administered by the Committee.

The Committee shall have full authority to establish the rules and regulations relating to the Plan, to interpret the Plan and those rules and regulations, to select Participants in the Plan, to determine the Performance Periods, Performance Targets and Target Award Percentages applicable to each Participant and the amount of compensation payable to each Participant upon the achievement of such targets.

5. Determination of Awards.

For each Performance Period, the Committee shall designate and establish the executive officers, if any, who shall be Participants during that Performance Period and the Performance Targets and Target Award Percentages for each Participant.

The Committee shall notify each Participant of his or her Target Award Percentage and Performance Target for the Performance Period.

Participant Information

The amount of a Participant Award is equal to the product of his or her Target Award Percentage and his or her Base Salary.

The Committee in its sole discretion may reduce any Award to any Participant to any amount, including zero, prior to the written certification of the Committee of the amount of such Award.

The maximum amount of Awards that any participant may receive with respect to any fiscal year of the Company during which the Plan is in effect is $1 million.

6. Changes to the Target.

The Committee may change the Performance Targets to reflect a change in corporate capitalization, a corporate transaction, or the occurrence of unexpected events, prior to the expiration of 25% of the relevant Performance Period.

7. Payment of Awards.

As soon as practicable after the close of a Performance Period, the Committee shall review and approve each Participant Award. Each Award shall be paid in a single lump sum cash payment as soon as practicable after the close of the Performance Period, but no later than 120 days after the close of the Performance Period.

8. Designation of Beneficiary.

A Participant may designate a beneficiary or beneficiaries who, in the event of the Participant's death prior to full payment of any Award hereunder, shall receive payment of any Award due under the Plan.

9. Amendments.

The Committee may at any time amend (in whole or in part) this Plan.

10. Termination.

The Committee may terminate this Plan (in whole or in part) at any time.

11. Miscellaneous Provisions.

This Plan is not a contract between the Company and the executive officers or the Participants.

The Plan and all rights hereunder shall be construed in accordance with and governed by the laws of the State of Connecticut.

12. Stockholder Approval.

13. Effective Date.

The Dexter Corporation

3/7/96

Enter text✕

What the Dexter Corp Annual Report 10-K Exhibit 10F Is

The Dexter Corp Annual Report 10-K Exhibit 10F is a formal contract or material agreement attached as an exhibit to a company’s Form 10-K filing with the U.S. Securities and Exchange Commission. Exhibits numbered in the 10 series typically include material contracts, leases, licensing arrangements, or similar binding agreements that a registrant must disclose. Exhibit 10F provides readers and regulators with the actual text of the contract referenced in the body of the 10-K, establishing the parties’ obligations, effective dates, and key terms relied on by auditors and investors.

Why Exhibit 10F Matters for Reporting and Compliance

Including Exhibit 10F with a Form 10-K provides transparency about material contractual obligations and supports SEC disclosure requirements; it also preserves the precise contractual language for legal review and investor due diligence.

Why Exhibit 10F Matters for Reporting and Compliance

Who Typically Prepares and Reviews Exhibit 10F

Final sign-off often requires designated corporate officers to attest that the exhibit is accurate and to authorize its filing with the SEC.

  • General Counsel and corporate legal teams prepare and notarize executed copies for disclosure and internal recordkeeping.
  • Chief Financial Officer or controller ensures the exhibit aligns with financial statement notes and materiality disclosures.
  • Investor relations and SEC filing specialists coordinate exhibit formatting and inclusion with the Form 10-K submission.

Typical Signatories and Their Roles

General Counsel

Leads drafting and legal review, confirms the exhibit’s wording meets disclosure obligations, and coordinates any required corporate approvals or board resolutions before inclusion in the Form 10-K.

Chief Financial Officer

Verifies that contractual terms described in Exhibit 10F are reflected in financial disclosures, evaluates materiality, and confirms the exhibit supports SEC reporting and auditor review.

Core Elements to Include in a Professional Exhibit 10F

Exhibit 10F should be a complete, self-contained document. Use clear headings, executed signature blocks, and consistent formatting so reviewers can quickly locate key obligations and dates.

Parties

Full legal names and entity types for each contracting party, including any d/b/a references and the state or country of formation to avoid ambiguity in enforcement.

Effective Date

The exact effective date and, if different, execution dates; specify whether obligations begin on signing or a separate operational start date.

Scope of Obligations

Clear description of duties, deliverables, payment terms, and performance metrics that define the parties’ responsibilities under the agreement.

Term and Termination

Length of the agreement, renewal mechanics, and termination rights, including notice periods and remedies for breach or insolvency events.

Confidentiality & IP

Any nondisclosure provisions and intellectual property ownership or license terms that affect future reporting or carve-outs in financial statements.

Signatures

Executed signature blocks with printed names, titles, dates, and any notarization or witness blocks required by state or industry rules.

Step-by-Step: Preparing Exhibit 10F for Execution

A clear sequential process reduces errors and ensures Exhibit 10F is ready for SEC inclusion and internal records.

  • 01
    Draft Review: Collect and reconcile contract text with financial disclosures.
  • 02
    Legal Approval: Obtain internal and outside counsel sign-off on material terms.
  • 03
    Execution: Have authorized signatories sign and date the document.
  • 04
    File With 10-K: Include signed exhibit in the Form 10-K submission package to the SEC.

How to Configure an Online Execution Workflow

Configure eSignature fields and recipient order to match corporate approval and execution requirements before distributing Exhibit 10F for signature.

Field Configuration
Signature Block Assigned to corporate officer; require printed name and title fields.
Date Field Auto-populate MM/DD/YYYY on signer completion.
Notary Block Include audio-video or notarization placeholder where RON or in-person notarization is needed.
Routing Order Set sequential routing: internal reviewer → legal → finance → external counterparty.

Where Exhibit 10F Goes After Execution

Understand the routing steps so executed exhibits are promptly included in SEC filings and retained for audits and legal holds.

  • Primary Archive: Store executed original in corporate records.
  • SEC Filing: Attach the signed exhibit to the Form 10-K filing package.
  • External Distribution: Provide countersigned copies to counterparties and counsel.
  • Audit Access: Ensure auditors can access the executed exhibit and metadata.

Digital Signing and Submission Considerations

Choose platform settings that preserve evidentiary metadata and, where needed, support remote online notarization or in-person acknowledgment workflows.

  • Authentication: Use email + code or stronger methods for attribution.
  • Audit Trail: Capture IP, timestamps, and signer actions.
  • Document Formats: Use PDF or DOCX; ensure final PDF is archival-ready.

Timelines and Deadlines Related to Exhibit 10F

Timing matters for effective disclosure; align the exhibit’s execution date with the Form 10-K reporting calendar and internal review schedules.

Execution Before Filing:

Sign exhibits prior to Form 10-K submission when referenced as existing material contracts.

SEC Filing Deadline:

Follow the Form 10-K due date based on filer category (accelerated/smaller reporting company).

Board Approval:

Obtain any required board or committee approvals before execution.

Retention Start Date:

Retention begins on execution or effective date, as appropriate.

Notarization Timing:

Complete notarization at signing or per state RON rules if remote notarization is used.

Common Preparation Pitfalls to Avoid

  • Using inconsistent party names between the contract and corporate formation documents, causing identity and enforcement issues.
  • Omitting executed signature blocks or datestamps, which can invalidate the exhibit for SEC or audit purposes.
  • Failing to include required notarization or witness blocks for state-specific enforceability of certain acknowledgements.
  • Sending the wrong version for signature rather than the fully approved, final contract, leading to multiple re-signatures and filing delays.

Key Risks and Potential Penalties for Incorrect Exhibits

SEC Non-Compliance: May trigger restatement or comment letter
Contractual Disputes: Ambiguous terms increase litigation risk
Tax Penalties: Incorrect disclosure can affect tax reporting
Invalid Execution: Missing notarization may limit enforceability
Audit Findings: Auditors may question adequacy of disclosures
Reputational Harm: Delayed or corrected filings can harm investor trust

Real-World Examples of Contract Workflows and Compliance

These customer examples illustrate practical execution and recordkeeping patterns for material contracts used as SEC exhibits.

Optica Ventures

The interface is simple and easy-to-use for our team; more importantly, it is just as easy for our customers.

  • Used eSignature to collect counterparty signatures across states.
  • Resulted in consistent executed exhibits and an auditable trail that simplified disclosure review and internal archiving for future audits.

Tech Data

Tech Data uses airSlate SignNow to improve our internal and external customer service while increasing our speed to revenue.

  • Centralized contract execution and retained audit logs.
  • Streamlined the inclusion of signed exhibits in SEC-related reporting cycles and reduced manual scanning and indexing work.

eSignature Vendor Pricing Snapshot for Document Execution

This vendor comparison highlights typical starting prices and key plan characteristics; signNow appears first and pricing reflects common annual-billing public tiers.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day trial Varies Varies Varies Varies
Bulk Send Yes Yes Yes Yes Varies
Audit Trail Yes Yes Yes Yes Yes
Envelope Cap No cap 100 envelopes/user/year Varies Varies Varies

FAQs and Troubleshooting for Exhibit Execution and eSignatures

Common questions about validity, notarization, and retention of executed exhibits with electronic signatures are addressed below to reduce filing risk.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users